chr20-3661053-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_022139.4(GFRA4):c.283G>A(p.Glu95Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,450,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )
Consequence
GFRA4
NM_022139.4 missense
NM_022139.4 missense
Scores
10
8
1
Clinical Significance
Conservation
PhyloP100: 5.68
Genes affected
GFRA4 (HGNC:13821): (GDNF family receptor alpha 4) The protein encoded by this gene is a member of the GDNF receptor family. It is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for persephin, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for RET-associated diseases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.825
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFRA4 | NM_022139.4 | c.283G>A | p.Glu95Lys | missense_variant | 2/6 | ENST00000290417.7 | NP_071422.1 | |
GFRA4 | NM_145762.3 | c.283G>A | p.Glu95Lys | missense_variant | 2/5 | NP_665705.1 | ||
GFRA4 | XM_005260793.2 | c.283G>A | p.Glu95Lys | missense_variant | 2/4 | XP_005260850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFRA4 | ENST00000290417.7 | c.283G>A | p.Glu95Lys | missense_variant | 2/6 | 1 | NM_022139.4 | ENSP00000290417.2 | ||
GFRA4 | ENST00000319242.8 | c.283G>A | p.Glu95Lys | missense_variant | 2/5 | 1 | ENSP00000313423.3 | |||
GFRA4 | ENST00000477160.1 | n.283G>A | non_coding_transcript_exon_variant | 2/4 | 1 | ENSP00000435801.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151580Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151580
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000307 AC: 2AN: 65192Hom.: 0 AF XY: 0.0000520 AC XY: 2AN XY: 38466
GnomAD3 exomes
AF:
AC:
2
AN:
65192
Hom.:
AF XY:
AC XY:
2
AN XY:
38466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000339 AC: 44AN: 1299106Hom.: 0 Cov.: 37 AF XY: 0.0000343 AC XY: 22AN XY: 640820
GnomAD4 exome
AF:
AC:
44
AN:
1299106
Hom.:
Cov.:
37
AF XY:
AC XY:
22
AN XY:
640820
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151690Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74140
GnomAD4 genome
AF:
AC:
1
AN:
151690
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.283G>A (p.E95K) alteration is located in exon 2 (coding exon 2) of the GFRA4 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the glutamic acid (E) at amino acid position 95 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;T
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of methylation at E95 (P = 0.0115);Gain of methylation at E95 (P = 0.0115);
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at